Intraabdominal Infections (DBCOND0046593)

Identifiers

Synonyms
Intra Abdominal Infections / Infection, Intra-abdominal / Intra abdominal infection / Intra-Abdominal Infections / Intra-Abdominal Infection / Abdominal infection / Infectious disease of abdomen (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Amikacin
An aminoglycoside used to treat infections caused by more resistant strains of Gram negative bacteria and some Gram positive bacteria.
Aztreonam
A beta-lactam antibiotic used to treat select aztreonam sensitive gram negative bacteria.
Cefoperazone
A broad-spectrum cephalosporin antibiotic used for the treatment of bacterial infections in various locations, including the respiratory tract, abdomen, skin, and female genital tracts.
Cefotetan
An antibiotic medication used for the prophylaxis and treatment of various bacterial infections, including urinary tract infections, bone and joint infection, and lower respiratory tract infections.
Cefoxitin
A semi-synthetic, broad-spectrum antibiotic for parenteral administration used for the treatment of serious bacterial infections, such as urinary tract infection, blood infection, bone and joint infection, and lower respiratory tract infection.
Ceftazidime
An injected broad-spectrum third-generation cephalosporin beta-lactam antibiotic used to treat or prevent a variety of bacterial infections, including pneumonia, gynecological infections, bone and joint infections, and septicemia, among others.
Ceftriaxone
A broad-spectrum cephalosporin antibiotic used for the treatment of bacterial infections in various locations, such as in the respiratory tract, skin, soft tissue, and urinary tract.
Cilastatin
A renal dehydropeptidase inhibitor used to prevent degradation of imipenem. Both medications are used together to treat a variety of infections.
Clavulanic acid
A beta lactamase inhibitor used to enhance the effectiveness of beta lactam antibiotics.
Eravacycline
A tetracycline antibiotic used to treat complicated intra-abdominal infections.
Imipenem
A carbapenem antibiotic normally administered with cilastatin to treat a variety of infections.
Piperacillin
A penicillin antibiotic combined with tazobactam to treat piperacillin-resistant, piperacillin/tazobactam­ susceptible, β-lactamase generating strains of several bacteria.
Sulbactam
An beta-lactamase inhibitor antibiotic combined with other antibiotics to treat a variety of susceptible bacterial infections.
Technetium Tc-99m exametazime
A radiopharmaceutical diagnostic agent used as an adjunct for scintigraphy in the detection of altered regional cerebral perfusion in stroke.
No drug targets
Tobramycin
An aminoglycoside antibiotic used to treat cystic fibrosis-associated bacterial, lower respiratory tract, urinary tract, eye, skin, bone, and skin structure infections.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02979951
Fosfomycin i.v. for Treatment of Severely Infected PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03482245
The Role of Circadian Clock Proteins in Innate and Adaptive ImmunityNo drug interventionsbasic_scienceNot Availablerecruiting
NCT02831556
Point of Care 3D Ultrasound for Various Applications: A Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04612413
A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patientstreatment2active_not_recruiting
NCT03744741
HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01763008
A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract InfectionsNo drug interventionsNot AvailableNot Availablecompleted
NCT03544203
Multicentre Observational Study on Community Acquired Intraabdominal Infections ManagementNo drug interventionsNot AvailableNot Availablecompleted
NCT04700787
Safety, Tolerability, and Pharmacokinetics of Sulopenem in AdolescentsNo drug interventionstreatment1withdrawn
NCT03862378
Prediction of Intra-abdominal Infectious Complication by Drainage Fluid AnalysisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01069900
Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal InfectionNo drug interventionstreatment3completed
NCT03061500
Prognostic Value of Proadrenomedullin in Intra-abdominal SepsisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03358576
Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)treatment3completed
NCT03997929
Peritoneal 1.3-ß-D-glucan for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients (pBDG2)No drug interventionsNot AvailableNot Availablecompleted
NCT00769171
Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)No drug interventionstreatment3completed
NCT06304779
The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAINo drug interventionspreventionNot Availableactive_not_recruiting
NCT00481702
A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)No drug interventionstreatment3completed
NCT04519086
The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30No drug interventionsdiagnosticNot Availablesuspended
NCT00952796
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infectionstreatment4completed
NCT00488345
Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of AgeNo drug interventionstreatment2completed
NCT04882085
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese AdultsNo drug interventionstreatment4completed
NCT04229511
Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05127109
The PASTDUe Nutrition Ecosystem Project (PASTDUe)No drug interventionstreatment4recruiting
NCT05187871
Study for Rapid Diagnosis of Postoperative Abdominal InfectionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02739997
Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)No drug interventionstreatment3completed
NCT01561066
Autologous Fibrin Glues for Fistulas Closuretreatment1completed
NCT00630513
T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- SulbactamNo drug interventionstreatment4completed
NCT00244088
Study Evaluating the Etiology of Intra-Abdominal InfectionsNo drug interventionsNot AvailableNot Availablecompleted
NCT00230971
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)treatment4completed
NCT06507423
Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric IschemiaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05549076
Hellenic Registry for cIAIs (HERCO-II)No drug interventionsNot AvailableNot Availablecompleted
NCT02533869
The Optimization of a Low-dose Computed Tomography Protocol in Patients With Suspected Uncomplicated Acute AppendicitisNo drug interventionsdiagnosticNot Availablecompleted
NCT01721408
A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal InfectionNo drug interventionstreatment4completed
NCT00621192
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal InfectionsNo drug interventionstreatment1 / 2completed
NCT03354754
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)No drug interventionsbasic_science2terminated
NCT01789905
Tygacil Drug Use InvestigationNot AvailableNot Availablecompleted
NCT05628493
Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver DysfunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT01506271
Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)treatment2completed
NCT04240288
Procalcitonin Guided Antibiotic TherapyNo drug interventionsotherNot Availablewithdrawn
NCT01473836
A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infectiontreatment3completed
NCT04094818
HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected SepsisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01431326
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareNot AvailableNot Availablecompleted
NCT00827541
Post-Authorization Study Evaluating Safety Of TigecyclineNo drug interventionsNot AvailableNot Availablecompleted
NCT02442596
Abdominal SepsiS Study: Epidemiology of Etiology and OutcomeNo drug interventionsNot AvailableNot Availablecompleted
NCT00965848
A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract InfectionsNo drug interventionstreatment4completed
NCT05639504
Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED)No drug interventionsNot AvailableNot Availablewithdrawn